Clinical Trials on Hypersensitivity in United Kingdom

Total 3730 results

GlaxoSmithKline

Completed

Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

Dentine Sensitivity

United Kingdom
Imperial College London
National Institute for Health Research, United Kingdom

Completed

AZithromycin Against pLacebo in Exacerbations of Asthma (AZALEA)

Asthma

United Kingdom
University Hospital Southampton NHS Foundation...

Unknown

Distribution of Highly Sensitive Troponin in the Critically Unwell & Associated Mortality (DIGNITY)

Myocardial Infarction | Myocardial Injury

United Kingdom
Airsonett AB
Commitum AB; Croel AB

Completed

Efficacy Study of Temperature Controlled Laminar Airflow (TLA)-Treatment in Perennial Allergic Asthma (4A)

Asthma

Denmark, United Kingdom, Norway, Sweden, Germany, Finland
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
LEO Pharma

Completed

LEO19123 Cream in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United Kingdom, Finland, Canada, Denmark
GlaxoSmithKline

Completed

Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health

Dentin Sensitivity

United Kingdom
RSPR Pharma AB

Completed

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Asthma

Denmark, Poland, Bulgaria, United Kingdom
AstraZeneca

Completed

Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids (MESOS)

Asthma

Canada, Denmark, United Kingdom
Janssen Research & Development, LLC

Completed

A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16

Healthy Volunteers and Asthma

United Kingdom, Canada, Netherlands, Germany, Denmark, Belgium
Astellas Pharma Inc

Completed

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
AnaptysBio, Inc.

Completed

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

Eosinophilic Asthma

United Kingdom, United States
Hoffmann-La Roche

Withdrawn

A Study of RO5036505 in Patients With Moderate to Severe Asthma

Asthma

United States, United Kingdom
Evelo Biosciences, Inc.

Completed

A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United Kingdom
Queen Mary University of London

Completed

The Effect of Autonomic Modulation on Symptoms in Patients With Reflux Hypersensitivity

Gastro Esophageal Reflux

United Kingdom
Johns Hopkins University

Completed

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy

Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
King's College London
LighterLife (UK) Ltd

Completed

The Impact Of An Intermittent Energy Restricted Diet On Insulin Sensitivity In Men and Women With Central Obesity (Met-IER)

Obesity, Abdominal

United Kingdom
Astellas Pharma Inc

Completed

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
Evelo Biosciences, Inc.

Completed

A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United Kingdom
Alton Melton
The Cleveland Clinic

Active, not recruiting

Boiled Peanut Oral Immunotherapy (BPOIT)

Peanut Hypersensitivity

United States
Bristol-Myers Squibb

Completed

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis

Healthy Subjects and Atopic Dermatitis Subjects

United Kingdom
Kari Nadeau, MD, PhD
University of Chicago; Stanford University; Children's Hospital Medical Center... and other collaborators

Recruiting

Seal, Stopping Eczema and Allergy Study

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Eczema, Infantile

United States, United Kingdom
Allertein Therapeutics, LLC
Consortium of Food Allergy Research

Completed

Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
Children's Hospital of Philadelphia

Completed

Milk Oral Immunotherapy in Children to Treat Food Allergy

Milk Hypersensitivity

United States
DBV Technologies

Active, not recruiting

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age (EPITOPE)

Peanut Allergy

United States, Canada, Australia, France, Germany, United Kingdom, Ireland, Netherlands
Novartis Pharmaceuticals

Completed

AWARE - Chronic Urticaria (AWARE)

Chronic Urticaria

United Kingdom
Queen Margaret University
Barry Callebaut

Completed

Effect of Polyphenol-rich Dark Chocolate on Insulin Sensitivity in Normal Weight and Overweight Adults

Insulin Resistance

United Kingdom
Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Tolerance Following Peanut Oral Immunotherapy (PNOIT2)

Peanut Allergy

United States
Novartis
Genentech, Inc.; Tanox

Completed

Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma

Asthma

Canada, Germany, Spain, Belgium, Switzerland, Israel, Portugal, Greece, Hungary, Poland, Ireland, Norway, Denmark, Sweden, Italy, United Kingdom, Turkey
University of North Carolina, Chapel Hill
Genentech, Inc.

Completed

Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy (PAIE/Xolair)

Peanut Hypersensitivity

United States
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists (eXplore)

Allergic Asthma

United States, Sweden, United Kingdom, France, Canada, Germany, Netherlands
National Institute of Allergy and Infectious Diseases...
Asthma and Allergic Diseases Cooperative Research Centers

Completed

Study of Milk Allergy and Tolerance in Children

Milk Hypersensitivity | Food Hypersensitivity

United States
Boston Children's Hospital
McMaster University

Completed

Evaluating the Effectiveness of a Handbook for Parents of Children Newly Diagnosed With Food Allergy

Hypersensitivity, Food

United States
Mundipharma Research Limited

Completed

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

Asthma

United Kingdom, Sweden, Australia, New Zealand, Slovakia
University of Edinburgh
NHS Lothian; NHS Greater Glasgow and Clyde; Abbott Diagnostics Division

Completed

High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome (High-STEACS)

Myocardial Infarction | Acute Coronary Syndrome

United Kingdom
National Jewish Health

Completed

The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy (IMMULITE 2000)

Egg Allergy | Peanut Allergy | Milk Allergy

United States
DBV Technologies
Todd D. Green MD, DBV Technologies

Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Peanut Allergy

United States
Lynda Schneider

Completed

Xolair Enhances Oral Desensitization in Peanut Allergic Patients

Peanut Allergy

United States
Boston Scientific Corporation

Completed

Bronchial Thermoplasty Global Registry (BTGR)

Asthma

Spain, Italy, Germany, Netherlands, Australia, Czechia, South Africa, United Kingdom
Aimmune Therapeutics, Inc.

Completed

Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) (PALISADE)

Peanut Allergy

United States, Spain, Ireland, Netherlands, Canada, United Kingdom, Germany, Denmark, Italy, Sweden
Aimmune Therapeutics, Inc.

Completed

PALISADE Follow-on Study (ARC004)

Peanut Allergy

United States, Spain, Netherlands, Italy, Canada, Germany, Ireland, Sweden, United Kingdom
UCB Biopharma SRL

Completed

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Atopic Dermatitis

Bulgaria, Germany, Netherlands, United Kingdom
University of North Carolina, Chapel Hill

Completed

Oral Immunotherapy (OIT) for Peanut Allergy (PnOIT3)

Peanut Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Interventional Study of Milk Allergy

Milk Hypersensitivity | Food Hypersensitivity

United States
SkyePharma AG

Completed

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma

Asthma

United Kingdom, Germany, Hungary, Poland, Romania
Massachusetts General Hospital
Vedanta Biosciences, Inc.

Recruiting

VE416 for Treatment of Food Allergy

Peanut Allergy

United States
Rima Rachid

Completed

Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients

Peanut Allergy

United States
Genentech, Inc.

Terminated

A Safety and Efficacy Study of Xolair in Peanut Allergy

Allergy

United States
Weill Medical College of Cornell University

Completed

Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy

Peanut Allergy

United States
Massachusetts General Hospital

Completed

Oral Peanut Immunotherapy (PNOIT)

Peanut Allergy

United States

Clinical Trials on Hypersensitivity in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations